Archive note added September 22, 2026: The item below was published on this site in January 2020 and links to a December 2017 report. It is historical news, not a current treatment guide. For current information, read our GLP-1 and weight-loss guide, 2026 drug update, and cost and coverage guide.
Original archived item
A new diabetes drug that lowers blood sugar and also helps people lose weight has been approved by the U.S. Food and Drug Administration.
The once-a-week injection drug Ozempic (semaglutide) is approved for people with type 2 diabetes. It stimulates the body’s insulin production and reduces appetite, the Associated Press reported.